Showing results (2811-2820 of 6,780) with videos related to
Sort By:
Pageof 678
Clinical Therapeutics|August 4, 2010
Impact of the implementation of a sepsis protocol for the management of fluid-refractory septic shock: A single-center, before-and-after studyPayal K Gurnani, Gourang P Patel, Christopher W Crank, et al.Clinical Therapeutics|August 4, 2010
Relative effectiveness of budesonide/formoterol and fluticasone propionate/salmeterol in a 1-year, population-based, matched cohort study of patients with chronic obstructive pulmonary disease (COPD): Effect on COPD-related exacerbations, emergency department visits and hospitalizations, medication utilization, and treatment adherenceLucie Blais, Amélie Forget, Sulabha RamachandranClinical Therapeutics|August 4, 2010
Cost-effectiveness of ranibizumab for the treatment of neovascular age-related macular degeneration in Germany: Model analysis from the perspective of Germany's statutory health insurance systemAljoscha S Neubauer, Frank G Holz, Stefan Sauer, et al.Clinical Therapeutics|August 4, 2010
An open-label, randomized, single-center, two-period, phase I, crossover study of the effect of zibotentan (ZD4054) on the pharmacokinetics of midazolam in healthy male volunteersHelen K Tomkinson, John V Kemp, Thomas Wollseifen, et al.Clinical Therapeutics|August 4, 2010
Pharmacokinetics, analgesic effect, and tolerability of a single preprocedural dose of intranasal fentanyl in patients undergoing drain removal after breast reduction or augmentation surgery: A prospective, randomized, double-blind, placebo-controlled studyNicole M L Veldhorst-Janssen, Audrey A A Fiddelers, Paul-Hugo M van der Kuy, et al.Clinical Therapeutics|August 6, 2010
Plerixafor: A chemokine receptor-4 antagonist for mobilization of hematopoietic stem cells for transplantation after high-dose chemotherapy for non-Hodgkin's lymphoma or multiple myelomaMichael Steinberg, Matthew SilvaClinical Therapeutics|August 6, 2010
Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phaseAllan Gordon, Denis Callaghan, Donald Spink, et al.Clinical Therapeutics|August 6, 2010
Retrospective case series of three patients with plasma cell leukemia treated with bortezomib-based regimensGiuseppe Mele, Salvatore Pinna, Angela Melpignano, et al.Clinical Therapeutics|August 6, 2010
Efficacy of inhaled nitric oxide for hypoxic respiratory failure in term and late preterm infants by baseline severity of illness: a pooled analysis of three clinical trialsSergio G Golombek, Joseph N YoungClinical Therapeutics|July 20, 2010
Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteersFranklin K Johnson, Jeffrey G Stark, Frederick A Bieberdorf, et al.Pageof 678